What is the recommendation for the use of triptans and calcitonin gene related peptide receptors in patients with migraine and prior ischemic stroke?
No recommendations can be made for the use of triptans and calcitonin gene related peptide receptors in patients with migraine and prior ischemic stroke due to the lack of clinical evidence to quantify such risks.